Skip to main content
TipRanks
Go Ultimate75% OFF

Cogent Biosciences (COGT) Ratios

741 Followers

Cogent Biosciences Ratios

COGT's free cash flow for Q3 2026 was $-80.89M. For the 2026 fiscal year, COGT's free cash flow was decreased by $-108.00K and operating cash flow was $-80.79M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio14.235.327.099.8713.04
Quick Ratio14.235.327.099.8713.04
Cash Ratio4.881.761.395.2112.86
Solvency Ratio-1.08-3.51-3.39-2.98-3.92
Operating Cash Flow Ratio-4.13-3.73-4.02-4.42-3.44
Short-Term Operating Cash Flow Coverage-170.940.000.000.000.00
Net Current Asset Value$ 609.12M$ 224.86M$ 215.14M$ 219.89M$ 204.72M
Leverage Ratios
Debt-to-Assets Ratio0.270.050.060.070.01
Debt-to-Equity Ratio0.400.070.070.080.01
Debt-to-Capital Ratio0.280.060.070.070.01
Long-Term Debt-to-Capital Ratio0.270.000.000.000.00
Financial Leverage Ratio1.471.281.221.181.08
Debt Service Coverage Ratio-69.710.000.00-35.590.00
Interest Coverage Ratio-108.870.000.00-37.060.00
Debt to Market Cap0.040.000.000.000.00
Interest Debt Per Share1.590.170.240.400.08
Net Debt to EBITDA0.180.320.170.852.94
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT98.67%92.72%92.45%94.86%95.66%
Return on Assets (ROA)-35.08%-78.03%-61.39%-46.62%-31.14%
Return on Equity (ROE)-51.69%-99.83%-74.63%-54.84%-33.74%
Return on Capital Employed (ROCE)-38.16%-101.38%-75.61%-53.96%-35.14%
Return on Invested Capital (ROIC)-38.09%-100.80%-75.23%-53.68%-34.76%
Return on Tangible Assets-35.08%-78.03%-61.39%-46.62%-31.14%
Earnings Yield-5.75%-31.58%-41.08%-20.65%-21.75%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.490.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-751.020.000.000.000.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding751.020.000.000.000.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.64-2.00-1.93-2.02-1.52
Free Cash Flow Per Share-1.65-2.01-1.96-2.14-1.56
Dividend Paid and CapEx Coverage Ratio-170.17-362.64-54.94-17.29-34.18
Capital Expenditure Coverage Ratio-170.17-362.64-54.94-17.29-34.18
Operating Cash Flow Coverage Ratio-1.04-11.90-8.15-6.04-18.63
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-4.65%-25.72%-33.40%-18.48%-18.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-17.41-3.17-2.43-4.84-4.60
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio8.993.161.822.661.55
Price-to-Free Cash Flow (P/FCF) Ratio-21.50-3.89-2.99-5.41-5.49
Price-to-Operating Cash Flow Ratio-21.62-3.90-3.05-5.72-5.66
Price-to-Earnings Growth (PEG) Ratio1.44-1.92-0.34-0.220.07
Enterprise Value Multiple-17.61-2.90-2.12-3.94-1.57
Enterprise Value5.66B729.38M434.01M558.79M115.78M
EV to EBITDA-17.61-2.90-2.12-3.94-1.57
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-21.28-3.50-2.77-4.45-1.91
EV to Operating Cash Flow-21.40-3.51-2.83-4.71-1.97
Tangible Book Value Per Share3.952.473.244.355.53
Shareholders’ Equity Per Share3.952.473.244.355.53
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-2.04-2.46-2.42-2.39-1.87
Tax Burden1.001.001.001.001.00
Interest Burden1.011.000.920.950.96
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.800.810.800.850.81

Currency in USD